Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029276 · ClinicalTrials.gov registry record · Phase 1
Magnetic Stimulation for Parkinson Disease
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT00029276 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 50 participants.
The verdict
NCT00029276, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
During transcranial magnetic stimulation (TMS), a magnetic coil is placed on the front part of the head. Electric current passes through the coil in brief pulses. Magnetism from the current produces a separate, small electric current inside the brain, which activates brain cells below the coil. This treatment may result in decreased depression and improved Parkinson's disease symptoms.
Interventions
- PROCEDURE Prefrontal transcranial magnetic brain stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2000-08 |
| Est. Completion | 2005-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00029276
The ClinicalTrials.gov registry entry for NCT00029276 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prefrontal transcranial magnetic brain stimulation is the first listed.
NCT00029276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00029276 about?
NCT00029276 is a clinical study titled "Magnetic Stimulation for Parkinson Disease". During transcranial magnetic stimulation (TMS), a magnetic coil is placed on the front part of the head. Electric current passes through the coil in brief pulses. Magnetism from the current produces a separate, small electric current inside the brain, which activates brain cells below the coil. This...
What is the current status of trial NCT00029276?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2000-08. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00029276?
The interventions under investigation include: Prefrontal transcranial magnetic brain stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT00029276?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.